GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 7,400.00
-500.00 (-6.33%)
At close: Mar 23, 2026
GC Genome Market Cap
GC Genome has a market cap or net worth of 175.02 billion as of March 23, 2026.
Market Cap
175.02B
Enterprise Value
138.92B
Revenue
31.53B
Ranking
n/a
PE Ratio
40.00
Stock Price
7,400.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 175.02B, a decrease of -33.33%. That is a compound annual growth rate of -40.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 175.02B | 8.50% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.11T |
| Celltrion | 44.21T |
| Sam Chun Dang Pharm. | 21.09T |
| ALTEOGEN | 18.91T |
| MedPacto | 198.45B |
| AptaBio Therapeutics | 197.22B |
| REYON Pharmaceutical | 186.53B |
| Vaxcell-Bio Therapeutics | 185.59B |